Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland: Cohort study

British Medical Journal

Volumn 319, Issue 7206, 1999, Pages 352-353

  Schlegel, Matthias ^a   Osterwalder, Joseph J ^a   Galeazzi, Renato L ^a   Vernazza, Pietro L ^b  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b Institute for Clinical Microbiology and Immunology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MUMPS VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MUMPS; PRIORITY JOURNAL; SWITZERLAND; VACCINATION;

EID: 0033533247     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7206.352     Document Type: Article

References (5)

1. 1 Expanded Programme on Immunization. Immunization coverage against measles, mumps and rubella. Wkly Epidemiol Rec 1993;68:83-6.
2. 2 Germann D, Ströhle A, Eggenberger K, Steiner CA, Matter L. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis 1996;28:235-8.
3. 3 D'Argenio P, Citarella A, Selvaggi MT, Benvento CPN. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. Vaccine 1998;16:818-22.
4. 4 Anderson RM, May RM. Modern vaccines: immunisation and herd immunity. Lancet 1990;335:641-5.
5. 5 Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, et al. The elimination of indigenous measles, mumps, and rubella from Finland by 12-year, two-dose vaccination program. N Engl J Med 1994;331:1397-402.